The global Upper Respiratory Tract Infection Treatment Market report published by Value Market Research, the continuous changes in climate and rising pollution around the globe is the primary factor for increasing cases of upper respiratory tract infection. Availability of OTC of topical solution for upper respiratory tract infection is propelling the growth of the market. Also, changing the lifestyle of people and expanding medical insurance will surge the demand of the market. In addition, growing awareness of people about their health and rising expenditure on personal hygiene will also propel the growth of the market. Rising medical infrastructure and favorable reimbursement scenarios in developed regions are responsible for the strong growth of the market. However, increasing incidences of allergy after topical treatment may hamper the growth of the market.
The major players in the upper respiratory tract infection treatment market include Alcon, Inc., Merck & Co., Inc., Collegium Pharmaceutical, Inc., GlaxoSmithKline plc and Verona Pharma Plc, Pfizer Inc. Teva Pharmaceuticals, Hospira,Inc. Sandoz, Inc..
Upper Respiratory Tract Infection Treatment Market Segmentation
By treatment type
- Topical treatment
- Cough suppressant
- Nasal decongestants
- Others
- Drug Treatment
- Antibiotics
- NSAIDs
- Other
By distribution Channel
- Hospital Pharmacies
- Retail Pharmacies and Drug Stores
- Online Pharmacies
The upper respiratory tract infection treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Source: https://www.valuemarketresearch.com/report/upper-respiratory-tract-infection-treatment-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.